Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22

Extracellular ATP: effects, sources and fate. Biochem J (1986) 8.45

Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 4.50

Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol (1986) 3.66

Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest (1986) 3.59

The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br J Pharmacol (1989) 3.50

Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A (1991) 3.22

Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 3.15

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest (1990) 2.61

Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle. Br J Pharmacol (1984) 2.36

Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol (1987) 2.30

Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci U S A (1984) 2.26

Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol (1992) 2.09

The role of endothelium in the control of vascular tone. Basic Res Cardiol (1986) 1.78

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest (1993) 1.73

Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol (1986) 1.69

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther (2009) 1.66

Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels. Br J Pharmacol (1988) 1.59

Nitric oxide activates multiple potassium channels in canine colonic smooth muscle. J Physiol (1995) 1.55

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest (1987) 1.55

The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscles. Br J Pharmacol (1990) 1.54

Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle. Br J Pharmacol (1986) 1.53

Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest (1991) 1.52

Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol (1989) 1.51

Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br J Pharmacol (1988) 1.51

Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol (1996) 1.46

Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol (1988) 1.45

Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest (1990) 1.44

In vivo EDRF activity influences platelet function. Br J Pharmacol (1988) 1.42

Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol (1989) 1.36

Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol (1988) 1.33

Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol (1987) 1.28

Maternal vasodilation in pregnancy: the emerging role of relaxin. Am J Physiol Regul Integr Comp Physiol (2011) 1.27

Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin. Br J Pharmacol (1989) 1.27

Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest (1993) 1.27

Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta. Br J Pharmacol (1986) 1.26

Involvement of cyclic GMP in non-adrenergic, non-cholinergic inhibitory neurotransmission in dog proximal colon. Br J Pharmacol (1992) 1.25

The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol (1986) 1.23

Role of nitric oxide in non-adrenergic, non-cholinergic inhibitory junction potentials in canine ileocolonic sphincter. Br J Pharmacol (1992) 1.22

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res (2016) 1.20

Inhibition of MHC II gene transcription by nitric oxide and antioxidants. Curr Pharm Des (2004) 1.19

A comparison of haemoglobin and erythrocytes as inhibitors of smooth muscle relaxation by the NANC transmitter in the BRP and rat anococcygeus and by EDRF in the rabbit aortic strip. Br J Pharmacol (1989) 1.18

NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. Proc Natl Acad Sci U S A (1990) 1.17

Evidence against the involvement of cytochrome P450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery. J Physiol (1997) 1.16

A possible role of airway epithelium in modulating hyperresponsiveness. Br J Pharmacol (1988) 1.15

Endothelium and the vasodilator action of rat calcitonin gene-related peptide (CGRP). Br J Pharmacol (1987) 1.14

Guanosine 5'-monophosphate modulates gating of high-conductance Ca2+-activated K+ channels in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1988) 1.13

Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium. Br J Pharmacol (1989) 1.13

Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br J Pharmacol (1990) 1.12

Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed. Br J Pharmacol (1988) 1.12

Endothelium-derived relaxing factor and nitroprusside compared in noradrenaline- and K+-contracted rabbit and rat aortae. J Physiol (1988) 1.11

Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. Br J Pharmacol (1984) 1.11

Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br J Pharmacol (1996) 1.09

Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol (1991) 1.09

Selective inhibition by gossypol of endothelium-dependent relaxations augments relaxations to glyceryl trinitrate in rabbit coeliac artery. Br J Pharmacol (1987) 1.09

Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect. J Physiol (1986) 1.08

Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo. Br J Pharmacol (1990) 1.08

Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br J Pharmacol (1988) 1.06

Contribution of nitric oxide to the endothelium-dependent hyperpolarization in rat aorta. J Physiol (1994) 1.05

EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries. Br J Pharmacol (2000) 1.04

Effects of 8-bromo-cGMP on Ca2+ levels in vascular smooth muscle cells: possible regulation of Ca2+-ATPase by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A (1987) 1.04

Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br J Pharmacol (2002) 1.03

Reversible NO motion in crystalline [Fe(Porph)(1-MeIm)(NO)] derivatives. Inorg Chem (2008) 1.00

Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation. Br J Pharmacol (1990) 1.00

Short- and long-term interactions of endothelium and vascular smooth muscle in coculture: effects on cyclic GMP production. Proc Natl Acad Sci U S A (1986) 0.99

Mapping NO movements in crystalline [Fe(Porph)(NO)(1-MeIm)]. J Am Chem Soc (2009) 0.98

Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine. Br J Pharmacol (1993) 0.97

Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. Br J Pharmacol (1992) 0.97

Electrochemical nitric oxide sensors for physiological measurements. Chem Soc Rev (2010) 0.97

Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells. Br J Pharmacol (1989) 0.96

Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta. J Physiol (1989) 0.96

Vascular smooth muscle sensitivity to endothelium-derived relaxing factor is different in different arteries. Br J Pharmacol (1988) 0.95

A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases. Handb Exp Pharmacol (2009) 0.95

Tetragonal to triclinic--a phase change for [Fe(TPP)(NO)]. Inorg Chem (2009) 0.95

Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells. Br J Pharmacol (1991) 0.95

Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest (1994) 0.94

Inhibition by quinine of endothelium-dependent relaxation of rabbit aortic strips. Br J Pharmacol (1987) 0.94

Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat. Br J Pharmacol (1988) 0.94

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest (1994) 0.94

Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta. Br J Pharmacol (1989) 0.93

Endothelium-dependent relaxation of rabbit middle cerebral artery to a histamine H3-agonist is reduced by inhibitors of nitric oxide and prostacyclin synthesis. Br J Pharmacol (1992) 0.93

Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta. Br J Pharmacol (1991) 0.91

Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br J Pharmacol (1992) 0.90

Age-associated decrease in histamine-induced vasodilation may be due to reduction of cyclic GMP formation. Br J Pharmacol (1988) 0.90

Action of noradrenaline on isolated proximal and distal coronary arteries of rat: selective release of endothelium-derived relaxing factor in proximal arteries. Br J Pharmacol (1990) 0.90

Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation. Br J Pharmacol (1996) 0.89

Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed. Br J Pharmacol (1996) 0.89

Actions and interactions of NG-substituted analogues of L-arginine on NANC neurotransmission in the bovine retractor penis and rat anococcygeus muscles. Br J Pharmacol (1993) 0.89

The endothelium in health and disease. Tex Heart Inst J (1994) 0.89

Insensitivity of calcium-dependent endothelial stimulation in rat isolated aorta to the calcium entry blocker, flunarizine. Br J Pharmacol (1985) 0.88

The identification of nitric oxide as endothelium-derived relaxing factor. Circ Res (2013) 0.87

Dietary omega 3 polyunsaturated fatty acids augment endothelium-dependent relaxation to bradykinin in coronary microvessels of the pig. Br J Pharmacol (1988) 0.87

Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol (2001) 0.87

Effects of 8-bromo cyclic GMP and verapamil on depolarization-evoked Ca2+ signal and contraction in rat aorta. Br J Pharmacol (1995) 0.86

Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling. Curr Hypertens Rep (2013) 0.86

The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide. Br J Pharmacol (2010) 0.85

Regulation of obesity and insulin resistance by nitric oxide. Free Radic Biol Med (2014) 0.85

Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery. Br J Pharmacol (1988) 0.85

A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro. Br J Pharmacol (1987) 0.84

Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s). Br J Pharmacol (1990) 0.84

Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A (1977) 4.90

Cyclic GMP synthesis and function. Pharmacol Rev (1987) 4.89

Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 4.50

Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res (1977) 3.70

Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli. Nature (1978) 3.60

Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest (1986) 3.59

Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 3.15

Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature (1984) 2.77

Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci U S A (1991) 2.58

Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates. J Infect Dis (1980) 2.52

Nobel laureates' letter to President Bush. Washington Post (2001) 2.43

Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res (1978) 2.43

N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol (1990) 2.40

Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol (1991) 2.34

Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. J Cyclic Nucleotide Protein Phosphor Res (1983) 2.34

Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci U S A (1984) 2.26

Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science (1992) 2.25

Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem (1984) 2.15

Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett (1993) 2.14

Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol (2001) 2.08

Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol (1977) 1.98

Regulation of glycogen metabolism in polymorphonuclear leukocytes. J Biol Chem (1970) 1.98

Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A (1992) 1.93

Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J Biol Chem (1975) 1.77

Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ Res (1986) 1.69

Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem (1974) 1.68

Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem (1992) 1.65

Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol (1992) 1.63

Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun (1990) 1.61

Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol (2000) 1.59

Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem (1986) 1.58

A simple, sensitive protein-binding assay for guanosine 3':5'-monophosphate. Proc Natl Acad Sci U S A (1971) 1.57

Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucleotide Res (1977) 1.57

Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation. Proc Natl Acad Sci U S A (1977) 1.49

An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc Natl Acad Sci U S A (1998) 1.49

Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells. J Biol Chem (1971) 1.49

A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. Am J Physiol (1991) 1.47

Reversible inactivation of guanylate cyclase by mixed disulfide formation. J Biol Chem (1981) 1.46

NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit (2001) 1.42

Nonenzymatic formation of guanosine 3':5'-monophosphate from guanosine triphosphate. J Biol Chem (1974) 1.42

Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol (1990) 1.41

Colocalization of nitric oxide synthase and NADPH-diaphorase in the myenteric plexus of the rat gut. Neurosci Lett (1992) 1.40

Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun (1991) 1.39

Characterization of protein inhibitors of guanylate cyclase activation from rat heart and bovine lung. J Biol Chem (1978) 1.37

Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J Biol Chem (1990) 1.34

Cyclic nucleotide levels in incubations of guinea pig trachea. Biochim Biophys Acta (1974) 1.30

Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol (1993) 1.29

Soluble guanylate cyclase from rat lung exists as a heterodimer. J Biol Chem (1986) 1.28

Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol (1987) 1.27

Effects of Na+,K+-pump inhibitors and membrane depolarizing agents on acetylcholine-induced endothelium-dependent relaxation and cyclic GMP accumulation in rat aorta. Eur J Pharmacol (1985) 1.27

Nitric oxide and cGMP signaling. Adv Pharmacol (1995) 1.26

Sodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo cyclic GMP. Proc Natl Acad Sci U S A (1982) 1.26

Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem (1990) 1.26

Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle. Br J Pharmacol (1991) 1.25

Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol (1986) 1.24

Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther (1988) 1.23

Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation. Trans Assoc Am Physicians (1983) 1.22

Effects of guanosine 3',5'-monophosphate on glycerol production and accumulation of adenosine 3',5'-monophosphate by fat cells. J Biol Chem (1970) 1.21

Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP. Adv Cyclic Nucleotide Res (1979) 1.21

Effects of decapitation, ether and pentobarbital on guanosine 3',5'-phosphate and adenosine 3',5'-phosphate levels in rat tissues. Biochim Biophys Acta (1974) 1.20

Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase. Nature (1975) 1.17

Increased particulate and decreased soluble guanylate cyclase activity in regenerating liver, fetal liver, and hepatoma. Proc Natl Acad Sci U S A (1975) 1.17

Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am J Physiol Heart Circ Physiol (2001) 1.17

Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc Natl Acad Sci U S A (2000) 1.16

YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc Natl Acad Sci U S A (2001) 1.15

Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. N Engl J Med (1972) 1.15

Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J Biol Chem (1986) 1.15

Cellular signaling with nitric oxide and cyclic guanosine monophosphate. Semin Perinatol (2000) 1.14

Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol (2001) 1.14

Interaction of polymorphonuclear neutrophils with Escherichia coli. Effect of enterotoxin on phagocytosis, killing, chemotaxis, and cyclic AMP. J Clin Invest (1978) 1.13

Ca2+/calmodulin-dependent NO synthase type I: a biopteroflavoprotein with Ca2+/calmodulin-independent diaphorase and reductase activities. Biochemistry (1992) 1.13

ANP relaxes bovine tracheal smooth muscle and increases cGMP. Am J Physiol (1989) 1.12

Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med (1996) 1.12

Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun (1991) 1.12

Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc Natl Acad Sci U S A (2003) 1.11

Characterization of the receptor for heat-stable enterotoxin from Escherichia coli in rat intestine. J Biol Chem (1986) 1.11

Inhibition of Escherichia coli heat-stable enterotoxin by indomethacin and chlorpromazine. Infect Immun (1980) 1.11

Adenyl cyclase activity in particles from fat cells. Biochemistry (1969) 1.10

Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta. Circ Res (1984) 1.10

Requirement for a macromolecular factor for sodium azide activation of guanulate cyclase. J Cyclic Nucleotide Res (1975) 1.10

Properties and oxidative regulation of guanylate cyclase. J Cyclic Nucleotide Res (1977) 1.09

Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors. Br J Pharmacol (1993) 1.08

Assay of cyclic nucleotides by receptor protein binding displacement. Methods Enzymol (1974) 1.08

Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol (1988) 1.08

Clinical studies and applications of cyclic nucleotides. Adv Cyclic Nucleotide Res (1973) 1.07

Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation. Metabolism (1975) 1.07

The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. JAMA (1996) 1.06

Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation. Biochem Biophys Res Commun (1991) 1.06

Purification of soluble guanylate cyclase from rat liver. Proc Natl Acad Sci U S A (1979) 1.06

Purification and properties of a protein required for sodium azide activation of guanylate cyclase. J Biol Chem (1977) 1.05